AstraZeneca Pharmaceuticals LP

Registered Principal Details

Business Or Interest:
Research, development and sales of pharmaceuticals

Lobbying Interests:
All matters pertaining to the researching, development marketing, sale and distribution of medications.

CEO Name:
David Brennen
Executive Director

Contact
JK
Jacqueline Kirby
PO Box 15437
Wilmington, DE 19850-5737
(302) 885-5412
(302) 885-1110
jacqueline.kirby@astrazeneca.com
http://www.astrazeneca.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Budget Bill Subjects

Health Services: Medical Assistance and Related Programs
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance and Related Programs

Notification Date
2/8/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Regulation and Licensing
Biennial budget bill treatment of matter relating to
Regulation and Licensing

Notification Date
4/14/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Comments
the proposed expansion of the Pharmacy Scope of Practice

Topics Not Yet Assigned A Bill Or Rule Number

Combined Reporting
Development, drafting or introduction of a proposal relating to
Combined Reporting

Action Intended To Affect
Both Legislative Matter and Rule

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Medicaid
Development, drafting or introduction of a proposal relating to
Medicaid

Action Intended To Affect
Legislative Matter

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Medicaid
Development, drafting or introduction of a proposal relating to
Medicaid

Action Intended To Affect
Both Legislative Matter and Rule

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Medicare
Development, drafting or introduction of a proposal relating to
Medicare

Action Intended To Affect
Legislative Matter

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Medicare
Development, drafting or introduction of a proposal relating to
Medicare

Action Intended To Affect
Both Legislative Matter and Rule

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Phamaceutical Companies
Development, drafting or introduction of a proposal relating to
Phamaceutical Companies

Action Intended To Affect
Both Legislative Matter and Rule

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Pharmaceutical Companies
Development, drafting or introduction of a proposal relating to
Pharmaceutical Companies

Action Intended To Affect
Legislative Matter

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Prescriber Data
Development, drafting or introduction of a proposal relating to
Prescriber Data

Action Intended To Affect
Both Legislative Matter and Rule

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

  2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
Total Lobbying Expenditures 2011
January - June
$32,688.92
2011
July - December
$26,288.63
2012
January - June
$19,745.77
2012
July - December
$316.89
Total $79,040.20
Total Hours Communicating 2011
January - June
43.00
2011
July - December
17.00
2012
January - June
8.50
2012
July - December
0.00
Total 68.50
Total Hours Other 2011
January - June
63.50
2011
July - December
24.50
2012
January - June
25.00
2012
July - December
6.00
Total 119.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

No legislative bills/resolutions found.

Budget Bill Subjects

2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
50%
2011
July - December
50%
2012
January - June
25%
2012
July - December
25%
Total 45%

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
50%
2011
July - December
50%
2012
January - June
75%
2012
July - December
75%
Total 55%

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures